Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.5218
-0.0582 (-10.03%)
At close: Mar 5, 2026, 4:00 PM EST
0.5205
-0.0013 (-0.25%)
Pre-market: Mar 6, 2026, 5:22 AM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $120.77 million as of March 6, 2026. Its market cap has decreased by -61.38% in one year.
Market Cap
120.77M
Enterprise Value
143.43M
1-Year Change
-61.38%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $120.77M, a decrease of -87.87%. That is a compound annual growth rate of -25.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 134.24M | -81.29% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 124.42M |
| Aardvark Therapeutics | 124.33M |
| Alpha Cognition | 123.60M |
| Genelux | 118.68M |
| Black Diamond Therapeutics | 118.51M |
| Inovio Pharmaceuticals | 115.42M |
| Oncolytics Biotech | 114.60M |
| Precision BioSciences | 113.21M |